Abstract:Biodegradable aliphatic polyesters, especially polylactide (PLA), polyglycolide (PGA), and their copolymer poly(lactide-co-glycolide) (PLGA), are the most representative and widely used synthetic polymers in the field of tissue engineering and regenerative medicine. However, these polyesters often give rise to aseptic inflammation because of their acidic degradation products after implantation. Here, unidirectional shell-core structured fibers of chitosan/poly(lactide-co-glycolide) (i.e., CTS/PLGA) with acid-neutralizing capability were developed for addressing the noted issue by coating the PLGA fiber surfaces with a layer of the alkaline chitosan by coaxial electrospinning. Our results showed that during a period of 8-week degradation, the shell-layer of chitosan with its unique alkaline nature for acid-neutralization obviously hindered the pH decrease as a result of the degradation of PLGA-core. In a mocked acidic environment testing of the human dermal fibroblasts, chitosan-enabled acidity neutralization could significantly reduce in vitro the secretion of inflammatory factors and downregulate the expression of related inflammatory genes. Thereafter, biocompatibility assessment in vitro showed that the CTS/PLGA fibers had poorer cell adhesion capacity than the PLGA fibers but were cytocompatible and promoted cell migration and secretion of collagen. Moreover, subcutaneous embedding for two and four weeks in vivo revealed that the CTS/PLGA fibers significantly reduced the recruitment of inflammatory cells and the formation of foreign body giant cells (FBGCs). This study thereby demonstrated the evident acid-neutralizing effect of the chitosan-coating layer on alleviating the inflammatory responses caused by the acidic degradation products of the PLGA-core. Our highly aligned CTS/PLGA fibers, as a kind of quasi "pH-neutral fibers" with the acid-neutralizing capability, could be potentially applied for engineering those architecturally anisotropic tissues (e.g., tendon/ligament) toward improved efficacy of regeneration. STATEMENT OF SIGNIFICANCE: It is well known that acidic degradation products from representative aliphatic polyesters (e.g., PLA, PGA, and PLGA) give rise to the problem of aseptic inflammation. Various alkaline components acting as neutralizing agents have been used to address the noted issue. However, rather less attention has been paid to engineer these polyesters into a fibrous form with acid-neutralizing functionality. The present study proposes the concept of "pH-neutral fibers" and develops shell-core structured unidirectional fibers of chitosan/poly(lactide-co-glycolide) with acid-neutralizing capability for ameliorating inflammatory responses caused by the acidic degradation products of PLGA. It provides a comprehensive study encompassing fiber characterization and in vitro and in vivo evaluation, which would pave the way for developing sophisticated pH-neutral fibers for functional tissue regeneration.

Stable Acid-Responsive Electrospun Biodegradable Fibers As Drug Carriers and Cell Scaffolds.

Development of Random and Ordered Composite Fiber Hybrid Technologies for Controlled Release Functions

Ibuprofen-Loaded Electrospun Fibrous Scaffold Doped with Sodium Bicarbonate for Responsively Inhibiting Inflammation and Promoting Muscle Wound Healing in Vivo

A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents.

Electrospun silk fibroin/polyethylene oxide composite scaffolds with strontium or copper-doped hollow bioactive glass nanospheres for pH-triggered sustained drug release

Biodegradable Fibrous Scaffolds Composed Of Gelatin Coated Poly(Epsilon-Caprolactone) Prepared By Coaxial Electrospinning

Alginate-Based Electrospun Nanofibers and the Enabled Drug Controlled Release Profiles: A Review

Fabrication of Antimicrobial Multilayered Nanofibrous Scaffolds-Loaded Drug via Electrospinning for Biomedical Application

Emulsion Electrospinning of Nanofibrous Delivery Vehicles for the Controlled Release of Biomolecules and the in Vitro Release Behaviour of Biomolecules

Silk Fibroin Incorporated Electrospun Aliphatic Polyester Nanofiber Scaffolds with Excellent Dimensional Stability and Cytocompatibility

Electrospun acid-neutralizing fibers for the amelioration of inflammatory response

PLLA/HA Electrospin Hybrid Nanofiber Scaffolds: Morphology, In Vitro Degradation and Cell Culture Potential

Novel Biomimetic Fiber Incorporated Scaffolds for Tissue Engineering

Magnetically-driven drug and cell on demand release system using 3D printed alginate based hollow fiber scaffolds

Initial study on fibers and coatings for the fabrication of bioscaffolds

Electrospun quad-axial nanofibers for controlled and sustained drug delivery

A biodegradable core-sheath nanofibrous 3D hierarchy prepared by emulsion electrospinning for sustained drug release

Polylactic acid/silk fibroin composite hollow fibers as excellent controlled drug release systems

Innovative electrospun PCL/fibroin/l-dopa scaffolds scaffolds supporting bone tissue regeneration

Electrospun/3D-Printed Bicomponent Scaffold Co-Loaded with a Prodrug and a Drug with Antibacterial and Immunomodulatory Properties

Electrospun Fibers Control Drug Delivery for Tissue Regeneration and Cancer Therapy